Yu XL - Search Results

1

Panaxdiol saponins component promotes hematopoiesis by regulating GATA transcription factors of intracellular signaling pathway in mouse bone marrow.

Dai TY, Lan JJ, Gao RL, Zhao YN, Yu XL, Liang SX, Liu WB, Sun X. Dai TY, et al. Among authors: yu xl. Ann Transl Med. 2022 Jan;10(2):38. doi: 10.21037/atm-21-4800. Ann Transl Med. 2022. PMID: 35282082 Free PMC article.

2

[The effects of low polarity ginsenoside Rh4 on proliferation and differentiation in K562 leukemia cells].

Yu X, Gao R, Yin L, Wo L. Yu X, et al. Zhonghua Xue Ye Xue Za Zhi. 2015 Apr;36(4):347-9. doi: 10.3760/cma.j.issn.0253-2727.2015.04.020. Zhonghua Xue Ye Xue Za Zhi. 2015. PMID: 25916302 Free PMC article. Chinese. No abstract available.

3

Saponins from Panax notoginseng leaves improve the symptoms of aplastic anemia and aberrant immunity in mice.

Zhao Y, Sun X, Yu X, Gao R, Yin L. Zhao Y, et al. Biomed Pharmacother. 2018 Jun;102:959-965. doi: 10.1016/j.biopha.2018.03.175. Epub 2018 Apr 5. Biomed Pharmacother. 2018. PMID: 29710551

4

Research Progress on Chinese Medicine Immunomodulatory Intervention for Chronic Primary Immune Thrombocytopenia: Targeting Cellular Immunity.

Liu WB, Li S, Yu XL, Dai TY, Gao RL. Liu WB, et al. Among authors: yu xl. Chin J Integr Med. 2019 Jul;25(7):483-489. doi: 10.1007/s11655-019-3031-9. Epub 2019 Jul 5. Chin J Integr Med. 2019. PMID: 31278626 Review.

5

Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway.

Chian S, Zhao Y, Xu M, Yu X, Ke X, Gao R, Yin L. Chian S, et al. Anticancer Drugs. 2019 Sep;30(8):838-845. doi: 10.1097/CAD.0000000000000781. Anticancer Drugs. 2019. PMID: 31415285

6

Panaxdiol Saponins Component Promotes Hematopoiesis and Modulates T Lymphocyte Dysregulation in Aplastic Anemia Model Mice.

Zheng ZY, Yu XL, Dai TY, Yin LM, Zhao YN, Xu M, Zhuang HF, Chong BH, Gao RL. Zheng ZY, et al. Among authors: yu xl. Chin J Integr Med. 2019 Dec;25(12):902-910. doi: 10.1007/s11655-019-3049-z. Epub 2019 Dec 4. Chin J Integr Med. 2019. PMID: 31802424

7

Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Wu XL, Zhuang HF, Zhao YN, Yu XL, Dai TY, Gao RL. Wu XL, et al. Among authors: yu xl. Chin J Integr Med. 2020 May;26(5):324-329. doi: 10.1007/s11655-020-3252-y. Epub 2020 Apr 29. Chin J Integr Med. 2020. PMID: 32350801

8

Chinese Medicine Regulates DNA Methylation to Treat Haematological Malignancies: A New Paradigm of "State-Target Medicine".

Shen FL, Zhao YN, Yu XL, Wang BL, Wu XL, Lan GC, Gao RL. Shen FL, et al. Among authors: yu xl. Chin J Integr Med. 2022 Jun;28(6):560-566. doi: 10.1007/s11655-021-3316-7. Epub 2021 Jul 9. Chin J Integr Med. 2022. PMID: 34241803

9

Comprehensive analysis of the expression and prognosis for TNFAIPs in head and neck cancer.

Lan G, Yu X, Sun X, Li W, Zhao Y, Lan J, Wu X, Gao R. Lan G, et al. Sci Rep. 2021 Aug 3;11(1):15696. doi: 10.1038/s41598-021-95160-x. Sci Rep. 2021. PMID: 34344926 Free PMC article.

10

Ginsenoside Rk3 Inhibits the Extramedullary Infiltration of Acute Monocytic Leukemia Cell via miR-3677-5p/CXCL12 Axis.

Ma S, Huang Q, Hu Q, Gao R, Lan J, Yu X, Zhao Y, Shen F, Mi A, Wang B. Ma S, et al. Evid Based Complement Alternat Med. 2022 Dec 16;2022:3065464. doi: 10.1155/2022/3065464. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36569343 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

552 results

Search Page

Filters